Soriano-Arandes Antoni, Frick Marie Antoinette, García López-Hortelano Milagros, Sulleiro Elena, Rodó Carlota, Sánchez-Seco María Paz, Cabrera-Lafuente Marta, Suy Anna, De la Calle María, Santos Mar, Antolin Eugenia, Viñuela María Del Carmen, Espiau María, Salazar Ainara, Guarch-Ibáñez Borja, Vázquez Ana, Navarro-Morón Juan, Ramos-Amador José-Tomás, Martin-Nalda Andrea, Dueñas Eva, Blázquez-Gamero Daniel, Reques-Cosme Resurrección, Olabarrieta Iciar, Prieto Luis, De Ory Fernando, Thorne Claire, Byrne Thomas, Ades Anthony E, Ruiz-Burga Elisa, Giaquinto Carlo, Mellado-Peña María José, García-Alix Alfredo, Carreras Elena, Soler-Palacín Pere
Paediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Department of Paediatrics, Hospital Universitario La Paz, 28046 Madrid, Spain.
Pathogens. 2020 May 7;9(5):352. doi: 10.3390/pathogens9050352.
Zika virus (ZIKV) infection has been associated with congenital microcephaly and other neurodevelopmental abnormalities. There is little published research on the effect of maternal ZIKV infection in a non-endemic European region. We aimed to describe the outcomes of pregnant travelers diagnosed as ZIKV-infected in Spain, and their exposed children.
This prospective observational cohort study of nine referral hospitals enrolled pregnant women (PW) who travelled to endemic areas during their pregnancy or the two previous months, or those whose sexual partners visited endemic areas in the previous 6 months. Infants of ZIKV-infected mothers were followed for about two years.
ZIKV infection was diagnosed in 163 PW; 112 (70%) were asymptomatic and 24 (14.7%) were confirmed cases. Among 143 infants, 14 (9.8%) had adverse outcomes during follow-up; three had a congenital Zika syndrome (CZS), and 11 other potential Zika-related outcomes. The overall incidence of CZS was 2.1% (95%CI: 0.4-6.0%), but among infants born to ZIKV-confirmed mothers, this increased to 15.8% (95%CI: 3.4-39.6%).
A nearly 10% overall risk of neurologic and hearing adverse outcomes was found in ZIKV-exposed children born to a ZIKV-infected traveler PW. Longer-term follow-up of these children is needed to assess whether there are any later-onset manifestations.
寨卡病毒(ZIKV)感染与先天性小头畸形及其他神经发育异常有关。在非流行的欧洲地区,关于孕妇感染寨卡病毒的影响的已发表研究很少。我们旨在描述在西班牙被诊断为寨卡病毒感染的怀孕旅行者及其受影响儿童的结局。
这项对九家转诊医院进行的前瞻性观察队列研究纳入了在孕期或前两个月前往流行地区旅行的孕妇,或其性伴侣在前6个月内前往流行地区的孕妇。对寨卡病毒感染母亲的婴儿进行了约两年的随访。
163名孕妇被诊断为寨卡病毒感染;112名(70%)无症状,24名(14.7%)为确诊病例。在143名婴儿中,14名(9.8%)在随访期间出现不良结局;3名患有先天性寨卡综合征(CZS),另有11名可能与寨卡病毒相关的其他结局。CZS的总体发病率为2.1%(95%CI:0.4-6.0%),但在寨卡病毒确诊母亲所生的婴儿中,这一比例增至15.8%(95%CI:3.4-39.6%)。
在感染寨卡病毒的旅行孕妇所生的接触寨卡病毒的儿童中,发现总体有近10%的神经和听力不良结局风险。需要对这些儿童进行长期随访,以评估是否有任何迟发表现。